FDA OKs Lannett unit's ANDA filing for generic version of ABILIFY
Lannett Company said this week that its Silarx Pharmaceuticals subsidiary received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for Aripiprazole 1 mg/mL Oral Solution, the generic version of the antidepressant drug ABILIFY. Read More »